VolitionRX News

VolitionRX Analyst Ratings

BenzingaMar 27 21:37

Analysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF), Universal Health (UHS) and VolitionRX (VNRX)

TipRanksJan 3 20:23

EF Hutton Reiterates Buy on VolitionRX, Maintains $4.5 Price Target

BenzingaJan 3 02:34

VolitionRX Analyst Ratings

BenzingaJan 3 02:33

VolitionRX Analyst Ratings

BenzingaNov 22, 2023 03:11

Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (CVS), Madrigal Pharmaceuticals (MDGL) and VolitionRX (VNRX)

TipRanksNov 20, 2023 21:33

Cantor Fitzgerald Maintains Overweight on VolitionRX, Raises Price Target to $2.5

BenzingaNov 16, 2023 22:31

VolitionRX Analyst Ratings

BenzingaNov 16, 2023 22:30

EF Hutton Initiates Coverage On VolitionRX With Buy Rating, Announces Price Target of $4.5

BenzingaOct 30, 2023 22:58

VolitionRX Analyst Ratings

BenzingaOct 30, 2023 22:53

Cantor Fitzgerald Reaffirms Their Buy Rating on VolitionRX (VNRX)

TipRanksOct 27, 2023 21:26

Analysts Conflicted on These Healthcare Names: Bicycle Therapeutics (BCYC), Abbott Labs (ABT) and VolitionRX (VNRX)

TipRanksOct 27, 2023 19:20

Maxim Group Reaffirms Their Buy Rating on VolitionRX (VNRX)

TipRanksAug 23, 2023 22:25

VolitionRX Analyst Ratings

BenzingaAug 16, 2023 19:59

EF Hutton Assumes VolitionRX at Buy, Announces Price Target of $6

BenzingaJun 1, 2023 16:50

Maxim Group Sticks to Their Buy Rating for VolitionRX (VNRX)

TipRanksMar 21, 2023 19:57

EF Hutton Keeps Their Buy Rating on VolitionRX (VNRX)

TipRanksMar 17, 2023 00:48

Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), VolitionRX (VNRX) and Pharming Group (PHAR)

TipRanksMar 17, 2023 00:36

EF Hutton Reiterates Buy on VolitionRX, Maintains $6 Price Target

BenzingaMar 16, 2023 23:25

VolitionRX Analyst Ratings

Benzinga Analyst RatingsFeb 1, 2023 20:21